JoVE Logo

Oturum Aç

6.14 : Clearance Models: Compartment Models

Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume of distribution (Vss). If absorption is quicker than elimination for oral drugs, the terminal rate constant signifies elimination. Conversely, if absorption is slower, the rate constant indicates absorption.

The two-compartment model effectively represents the pharmacokinetics of less polar drugs distributed into a poorly blood-perfused compartment. This model accurately predicts the pharmacokinetics of the antibiotic vancomycin (Vancocin). Distributional clearance denotes clearance between two compartments: the central compartment, encompassing plasma and well-perfused organs, and the peripheral compartment, housing less-perfused organs.

Understanding these models and factors will help optimize drug dosing and minimize potential side effects.

Etiketler

Clearance ModelsPharmacokineticsOne compartment ModelTwo compartment ModelDrug EliminationPlasma ClearanceAminoglycoside AntibioticsVancomycinTerminal Rate ConstantVolume Of DistributionDistributional ClearanceDrug Dosing Optimization

Bölümden 6:

article

Now Playing

6.14 : Clearance Models: Compartment Models

Pharmacokinetics: Drug Excretion and Clearance

43 Görüntüleme Sayısı

article

6.1 : Drug Elimination: Overview

Pharmacokinetics: Drug Excretion and Clearance

922 Görüntüleme Sayısı

article

6.2 : Elimination Kinetics: First-Order and Zero-Order

Pharmacokinetics: Drug Excretion and Clearance

296 Görüntüleme Sayısı

article

6.3 : Renal Drug Excretion: Overview

Pharmacokinetics: Drug Excretion and Clearance

92 Görüntüleme Sayısı

article

6.4 : Renal Drug Excretion: Glomerular Filtration

Pharmacokinetics: Drug Excretion and Clearance

111 Görüntüleme Sayısı

article

6.5 : Renal Drug Excretion: Tubular Reabsorption

Pharmacokinetics: Drug Excretion and Clearance

68 Görüntüleme Sayısı

article

6.6 : Renal Drug Excretion: Tubular Secretion

Pharmacokinetics: Drug Excretion and Clearance

99 Görüntüleme Sayısı

article

6.7 : Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

Pharmacokinetics: Drug Excretion and Clearance

115 Görüntüleme Sayısı

article

6.8 : Hepatic Drug Excretion: Enterohepatic Cycling

Pharmacokinetics: Drug Excretion and Clearance

874 Görüntüleme Sayısı

article

6.9 : Hepatic Drug Excretion: Influencing Factors

Pharmacokinetics: Drug Excretion and Clearance

64 Görüntüleme Sayısı

article

6.10 : Drug Excretion: Pulmonary and Glandular Routes

Pharmacokinetics: Drug Excretion and Clearance

50 Görüntüleme Sayısı

article

6.11 : Drug Excretion: Miscellaneous Routes

Pharmacokinetics: Drug Excretion and Clearance

23 Görüntüleme Sayısı

article

6.12 : Drug Clearance: Overview

Pharmacokinetics: Drug Excretion and Clearance

41 Görüntüleme Sayısı

article

6.13 : Clearance Models: Physiological Models

Pharmacokinetics: Drug Excretion and Clearance

42 Görüntüleme Sayısı

article

6.15 : Clearance Models: Noncompartmental Models

Pharmacokinetics: Drug Excretion and Clearance

30 Görüntüleme Sayısı

See More

JoVE Logo

Gizlilik

Kullanım Şartları

İlkeler

Araştırma

Eğitim

JoVE Hakkında

Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır